Geneos Wealth Management’s Costamare CMRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-810
Closed -$10K 2787
2021
Q4
$10K Hold
810
﹤0.01% 2167
2021
Q3
$12K Buy
+810
New +$10.4K ﹤0.01% 2136
2019
Q1
Sell
-900
Closed -$4K 2414
2018
Q4
$4K Hold
900
﹤0.01% 2030
2018
Q3
$5K Hold
900
﹤0.01% 2046
2018
Q2
$7K Hold
900
﹤0.01% 1817
2018
Q1
$5K Hold
900
﹤0.01% 1838
2017
Q4
$5K Hold
900
﹤0.01% 1801
2017
Q3
$5K Hold
900
﹤0.01% 1743
2017
Q2
$6K Hold
900
﹤0.01% 1667
2017
Q1
$5K Hold
900
﹤0.01% 1671
2016
Q4
$5K Hold
900
﹤0.01% 1612
2016
Q3
$8K Hold
900
﹤0.01% 1432
2016
Q2
$6K Hold
900
﹤0.01% 1452
2016
Q1
$8K Buy
+900
New +$7.04K ﹤0.01% 1371

Other funds holding CMRE

Geneos Wealth Management's CMRE Position: Q1 2022 in Review

Geneos Wealth Management sold out of Costamare (CMRE) in Q1 2022, closing a stake of 810 shares — an estimated $10K sold.

Geneos Wealth Management first reported a position in CMRE in Q1 2016 and held it in 14 quarters. The position peaked at $12K in Q3 2021. 164 funds tracked by Wall St. Rank hold CMRE as of Q1 2022.

  • Geneos Wealth Management reported no remaining Costamare position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 810 Costamare shares in Q1 2022, an estimated $10K.
  • Geneos Wealth Management first reported a position in Costamare in Q1 2016 and held it in 14 quarters.
  • Geneos Wealth Management's Costamare position peaked at $12K in Q3 2021.
  • 164 funds tracked by Wall St. Rank held Costamare as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.